Perkins Coie Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.77M Sell
8,149
-14
-0.2% -$14.3K 1.62% 18
2026
Q1
$7.51M Buy
8,163
+185
+2% +$188K 1.44% 18
2025
Q4
$8.57M Buy
7,978
+279
+4% +$267K 1.6% 16
2025
Q3
$5.87M Buy
7,699
+1,066
+16% +$793K 1.11% 26
2025
Q2
$5.17M Buy
6,633
+62
+0.9% +$48.2K 0.88% 30
2025
Q1
$5.43M Buy
6,571
+521
+9% +$434K 1.23% 23
2024
Q4
$4.67M Buy
6,050
+136
+2% +$113K 1.03% 31
2024
Q3
$5.24M Buy
5,914
+156
+3% +$140K 1.16% 26
2024
Q2
$5.21M Buy
5,758
+1,313
+30% +$1.05M 1.21% 23
2024
Q1
$3.46M Buy
4,445
+571
+15% +$406K 0.81% 42
2023
Q4
$2.26M Buy
3,874
+3,390
+700% +$1.98M 0.57% 52
2023
Q3
$260K Buy
484
+30
+7% +$15.5K 0.07% 89
2023
Q2
$213K Hold
454
0.06% 83
2023
Q1
$156K Hold
454
0.05% 91
2022
Q4
$166K Hold
454
0.05% 88
2022
Q3
$147K Hold
454
0.06% 91
2022
Q2
$147K Hold
454
0.05% 89
2022
Q1
$130K Hold
454
0.04% 95
2021
Q4
$125K Hold
454
0.04% 94
2021
Q3
$105K Sell
454
-284
-38% -$70.1K 0.03% 109
2021
Q2
$169K Sell
738
-191
-21% -$38.4K 0.05% 96
2021
Q1
$174K Sell
929
-320
-26% -$62.6K 0.06% 97
2020
Q4
$211K Sell
1,249
-369
-23% -$55.1K 0.07% 99
2020
Q3
$239K Sell
1,618
-400
-20% -$61.9K 0.1% 90
2020
Q2
$331K Sell
2,018
-400
-17% -$61.4K 0.14% 86
2020
Q1
$335K Buy
2,418
+416
+21% +$57.2K 0.17% 82
2019
Q4
$263K Hold
2,002
0.11% 90
2019
Q3
$224K Hold
2,002
0.1% 91
2019
Q2
$222K Buy
2,002
+400
+25% +$47.1K 0.1% 91
2019
Q1
$208K Hold
1,602
0.1% 93
2018
Q4
$185K Hold
1,602
0.1% 91
2018
Q3
$172K Hold
1,602
0.08% 101
2018
Q2
$137K Hold
1,602
0.07% 106
2018
Q1
$124K Hold
1,602
0.06% 114
2017
Q4
$135K Hold
1,602
0.07% 107
2017
Q3
$137K Hold
1,602
0.07% 107
2017
Q2
$132K Hold
1,602
0.07% 105
2017
Q1
$135K Hold
1,602
0.08% 90
2016
Q4
$118K Hold
1,602
0.07% 95
2016
Q3
$129K Hold
1,602
0.08% 90
2016
Q2
$126K Hold
1,602
0.08% 89
2016
Q1
$115K Hold
1,602
0.08% 90
2015
Q4
$135K Hold
1,602
0.1% 79
2015
Q3
$134K Hold
1,602
0.11% 77
2015
Q2
$134K Buy
1,602
+801
+100% +$61K 0.1% 82
2015
Q1
$58K Buy
+801
New +$57K 0.04% 122

Other funds holding LLY

Perkins Coie Trust Company's LLY Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its Eli Lilly (LLY) stake by 0.17% in Q2 2026, selling an estimated $14.3K and leaving 8,149 shares worth $9.77M. The position accounts for 1.62% of the portfolio, ranked #18.

Perkins Coie Trust Company first reported a position in LLY in Q1 2015 and has held it in 46 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Perkins Coie Trust Company held 8,149 shares of Eli Lilly worth $9.77M as of Q2 2026.
  • Perkins Coie Trust Company sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
  • Eli Lilly made up 1.62% of Perkins Coie Trust Company's portfolio in Q2 2026, its #18 holding.
  • Perkins Coie Trust Company first reported a position in Eli Lilly in Q1 2015 and has held it in 46 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.